Following evaluation with Western blot, we found that only IAP-based PROTACs with a PEG3 linker, such as LCL-ER(dec), successfully destroyed the ERα in breast cancer MCF7 cells, while VHL- and CRBN-based ones did not induce degradation up to 10 μM. Here, ESR1 is linked to breast cancer.